Audiol Neurootol:中耳肌腱切除术对中耳肌肉阵挛性耳鸣、听力和听觉过敏长期影响研究

2018-04-19 AlexYang MedSci原创

最近,有研究人员评估了中耳肌腱切除(METR)对中耳肌肉阵挛性耳鸣的治疗效果,并且调查了对听力和听觉过敏的长期影响。研究包括了37名患有MEMT的病人,平均年龄为33.2±11.8岁。并且在2004年12月到2016年8月之间对所有的37名MEMT患者(41只耳朵)进行了METR。平均跟踪调查的时间为16.1个月。研究发现,手术后,34(91.9%)名患者在跟踪调查期间展现出了MEMT的完全消退,

最近,有研究人员评估了中耳肌腱切除(METR)对中耳肌肉阵挛性耳鸣的治疗效果,并且调查了对听力和听觉过敏的长期影响。

研究包括了37名患有MEMT的病人,平均年龄为33.2±11.8岁。并且在2004年12月到2016年8月之间对所有的37名MEMT患者(41只耳朵)进行了METR。平均跟踪调查的时间为16.1个月。研究发现,手术后,34(91.9%)名患者在跟踪调查期间展现出了MEMT的完全消退,并且3名患者表现出了部分响应。耳鸣严重程度视觉模拟量表(VAS)、耳鸣残疾量表(THI)和压力指数得分均值在术后都显著减少。在术后,没有患者发展成为听力损失或者听力过敏。甚至之前存在听力过敏的患者大多数都在术后得到了改善。症状的复发仅在1名患者中发生,并经历了补救手术且得到了改善。研究人员还观察到了1例术后面部麻痹患者,但在2周后完全恢复。

最后,研究人员指出,METR是MEMT治疗的有效的和安全的治疗选择,它对听力和听力过敏没有长期的副作用,且对耳鸣具有很高的控制率。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1877012, encodeId=3fa218e7012b9, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Jun 29 20:06:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053268, encodeId=6cb220532683d, content=<a href='/topic/show?id=6d7796998e0' target=_blank style='color:#2F92EE;'>#长期影响#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96998, encryptionId=6d7796998e0, topicName=长期影响)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Tue Feb 12 11:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295751, encodeId=8ed01295e51ee, content=<a href='/topic/show?id=86158052809' target=_blank style='color:#2F92EE;'>#耳鸣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80528, encryptionId=86158052809, topicName=耳鸣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306194, encodeId=fe11130619429, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512607, encodeId=473e151260e35, content=<a href='/topic/show?id=b5cf81043ed' target=_blank style='color:#2F92EE;'>#肌腱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81043, encryptionId=b5cf81043ed, topicName=肌腱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d6810483958, createdName=丁鹏鹏, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1877012, encodeId=3fa218e7012b9, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Jun 29 20:06:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053268, encodeId=6cb220532683d, content=<a href='/topic/show?id=6d7796998e0' target=_blank style='color:#2F92EE;'>#长期影响#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96998, encryptionId=6d7796998e0, topicName=长期影响)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Tue Feb 12 11:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295751, encodeId=8ed01295e51ee, content=<a href='/topic/show?id=86158052809' target=_blank style='color:#2F92EE;'>#耳鸣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80528, encryptionId=86158052809, topicName=耳鸣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306194, encodeId=fe11130619429, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512607, encodeId=473e151260e35, content=<a href='/topic/show?id=b5cf81043ed' target=_blank style='color:#2F92EE;'>#肌腱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81043, encryptionId=b5cf81043ed, topicName=肌腱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d6810483958, createdName=丁鹏鹏, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1877012, encodeId=3fa218e7012b9, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Jun 29 20:06:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053268, encodeId=6cb220532683d, content=<a href='/topic/show?id=6d7796998e0' target=_blank style='color:#2F92EE;'>#长期影响#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96998, encryptionId=6d7796998e0, topicName=长期影响)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Tue Feb 12 11:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295751, encodeId=8ed01295e51ee, content=<a href='/topic/show?id=86158052809' target=_blank style='color:#2F92EE;'>#耳鸣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80528, encryptionId=86158052809, topicName=耳鸣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306194, encodeId=fe11130619429, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512607, encodeId=473e151260e35, content=<a href='/topic/show?id=b5cf81043ed' target=_blank style='color:#2F92EE;'>#肌腱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81043, encryptionId=b5cf81043ed, topicName=肌腱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d6810483958, createdName=丁鹏鹏, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1877012, encodeId=3fa218e7012b9, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Jun 29 20:06:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053268, encodeId=6cb220532683d, content=<a href='/topic/show?id=6d7796998e0' target=_blank style='color:#2F92EE;'>#长期影响#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96998, encryptionId=6d7796998e0, topicName=长期影响)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Tue Feb 12 11:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295751, encodeId=8ed01295e51ee, content=<a href='/topic/show?id=86158052809' target=_blank style='color:#2F92EE;'>#耳鸣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80528, encryptionId=86158052809, topicName=耳鸣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306194, encodeId=fe11130619429, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512607, encodeId=473e151260e35, content=<a href='/topic/show?id=b5cf81043ed' target=_blank style='color:#2F92EE;'>#肌腱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81043, encryptionId=b5cf81043ed, topicName=肌腱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d6810483958, createdName=丁鹏鹏, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-21 docwu2019
  5. [GetPortalCommentsPageByObjectIdResponse(id=1877012, encodeId=3fa218e7012b9, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Fri Jun 29 20:06:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053268, encodeId=6cb220532683d, content=<a href='/topic/show?id=6d7796998e0' target=_blank style='color:#2F92EE;'>#长期影响#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96998, encryptionId=6d7796998e0, topicName=长期影响)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Tue Feb 12 11:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295751, encodeId=8ed01295e51ee, content=<a href='/topic/show?id=86158052809' target=_blank style='color:#2F92EE;'>#耳鸣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80528, encryptionId=86158052809, topicName=耳鸣)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3609256, createdName=zhu_jun9837, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306194, encodeId=fe11130619429, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512607, encodeId=473e151260e35, content=<a href='/topic/show?id=b5cf81043ed' target=_blank style='color:#2F92EE;'>#肌腱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81043, encryptionId=b5cf81043ed, topicName=肌腱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d6810483958, createdName=丁鹏鹏, createdTime=Sat Apr 21 11:06:00 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-21 丁鹏鹏

相关资讯

PLoS One:在法布里病病人中,心脏和肾脏功能障碍与晚期听力损失相关

法布里疾病(FD)是一种X染色体连锁的隐性遗传性溶酶体储存障碍,并且能够导致糖鞘脂(Gb3)在肾脏和心脏组织中的积累以及在中央和周围神经系统中的积累。除了明显的肾脏和心脏器官的参与之外,耳蜗症状比如高频听力损失和耳鸣经常能够出现,并且到目前为止没有全面的可利用资料来阐释这种现象。最近,有研究人员在患有FD的病人中,依据心脏和肾脏功能调查了听力损失的情况。研究人员在2012年和2016年之间招募了6

eNeuro:在噪音诱导的耳鸣和具有正常听力的人群中,弱中耳肌肉反射也许反应了耳蜗病变

慢性耳鸣在听力障碍中是普遍现象,并且到目前为止没有成功的治疗方法或者客观的诊断测试。最近,有研究人员进行了旨在调查耳鸣与中耳肌肉反射(MEMR)强度在具有正常听力和接近正常听力人群中的关系。研究人员将滴答声作为测试刺激来获得反射激活对耳声压的影响的宽带测量,并来利用侧宽带噪声引出反射。研究发现,与非耳鸣对照相比,反射强度在患有噪音诱导的持续性耳鸣和正常或者接近正常听力阈值的个体中显著减少。由于在耳

Eur J Oncol Nurs:化疗诱导的神经病变幸存者中听力损失和耳鸣研究

最近,有研究人员评估了幸存者这件的人口统计学、临床和疼痛特性、感觉测量、平衡、直觉压力、症状负担以及生活质量(QOL)之间的差异。这些幸存者接受了具有神经毒性的化疗(CTX)和报道具有化疗诱导的神经病变(CIN, n=217)、CIN和听力损失(CIN/HL,n=69)、或者CIN、听力损失和耳鸣。研究人员假设随着神经毒性的增加,幸存者具有更严重的治疗副作用结果。研究发现,与那些只患有CIN的幸存

Asian J Psychia:耳鸣还是幻听?如何区分?如何治疗?

幻听是精神分裂症患者经历的最常见的症状之一,其特征是在没有适当刺激的情况下主观地经历真实的声音。初级幻听可能由组织不良的声音组成,以简单的噪音,铃声,无差别的耳语或声音为特征。

Front Aging Neurosci:葡萄牙老年群体中耳聋和耳鸣生物标记的研究

老年性耳聋或者年龄相关的听力损失(ARHL)是一种普遍存在的健康问题。据估计,该病到2025年会影响超过15亿的人口。另外,耳鸣在大多数的老年性耳聋病人中存在。谷氨酸代谢性受体7(GRM7)和N-乙酰转移酶2(NAT2)是老年性耳聋的遗传标记的部分。最近,有研究人员探索了在葡萄牙人口群体样本中,听力损失的模式和GRM7和NAT2作为老年性耳聋和耳鸣遗传标记的可能。研究人员从78名个体(33名男性和